Drugs Begining With“r”
Investigated for use/treatment in alpha 1 antitrypsin deficiency, atopic dermatitis, and chronic obstructive pulmonary disease (COPD).
Investigated for use/treatment in adverse effects (chemotherapy) and bone marrow transplant.
Investigated for use/treatment in cardiovascular disorders, congestive heart failure, infertility, peripheral vascular disease, and scleroderma.
Diagnostic agent for radionuclide myocardial perfusion imaging (MPI)
For the treatment of diabetes mellitus type 1 and 2.
Regorafenib is indicated for the treatment of patients with metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if KRAS wild type, an anti-EGFR therapy. Regorafenib is also indicated for the treatment of patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and sunitinib malate.
For use during the induction and maintenance of general anesthesia.
For the treatment of hypertension and heart failure
Remoxipride is an atypical antipsychotic once used for the treatment of schizophrenia.
Investigated for use/treatment in multiple sclerosis.
For the treatment of stroke.